LI
RDY icon

Leap Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

Leap Investments’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-28,500
Closed -$214K – 473
2019
Q2 		$214K Buy
+28,500
New +$224K 0.29% 147

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Parametric Portfolio Associates
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
Aperio Group
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Leap Investments's RDY Position: Q3 2019 in Review

Leap Investments sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 28,500 shares — an estimated $214K sold.

Leap Investments first reported a position in RDY in Q2 2019 and held it in 1 quarter. The position peaked at $214K in Q2 2019. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

  • Leap Investments reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
  • Leap Investments sold 28,500 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $214K.
  • Leap Investments first reported a position in Dr. Reddy's Laboratories in Q2 2019 and held it in 1 quarter.
  • Leap Investments's Dr. Reddy's Laboratories position peaked at $214K in Q2 2019.
  • 152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on Leap Investments's 13F filing for Q3 2019, filed 13 Nov 2019.